Lloyd Price

OCTOBER 28, 2024

Regulatory Hurdles: The stringent regulatory environment in healthcare can increase development costs and delay time to market, making it less attractive to investors. Develop APIs and other integration tools to facilitate seamless data exchange. Conduct randomized controlled trials and real-world studies.

Interoperability 76

Interoperability healthcare technology HIPAA Leadership 76

Digital Health Global

NOVEMBER 12, 2024

23andMe tried to monetize its extensive genetic database by collaborating with pharmaceutical companies for drug research. While promising, drug development requires significant time and investment, delaying any financial returns and impacting the company’s short-term revenue.

Pharmaceuticals 88

Pharmaceuticals BioTech Leadership Drug Development 88

Digital Health Global

JANUARY 29, 2025

a leading provider of clinical development technology, today announced new data from the Tufts Center for the Study of Drug Development (CSDD)s PACT Consortium linking decentralized clinical trial (DCT) approaches to notably higher proportional representation among select demographic subgroups. Medable Inc.,

Drug Development 88

Drug Development Pharmaceuticals Digital Health 88

DrKumo Remote Patient Monitoring

JUNE 17, 2025

AI’s potential extends beyond diagnosis into areas such as drug discovery, where machine learning models are used to analyze complex biological data and identify promising therapeutic candidates. This approach can accelerate certain stages of drug development, helping to bring more targeted treatments to market faster.

Drug Development 52

Drug Development Health Data Patient Experience healthcare technology 52

Healthcare IT Today

JANUARY 22, 2025

Katherine Seay, Executive Vice President at Clinical Trial Media Diversity in healthcare needs to extend to every corner of the industry, from healthcare practitioners to the drug development and discovery process. One area where the need for diversity has never been greater is clinical trials.

EHR 78

EHR Drug Development Remote care Interoperability 78

Digital Health Global

JUNE 30, 2025

The firm’s mapped markets process, which identifies, collects, and analyzes micro-industry data, ensures highly precise revenue estimates, critical for investors, procurement specialists, and drug developers seeking strategic market positioning.

Life Science 88

Life Science Health science Drug Development Pharmaceuticals 88

Healthcare IT Today

DECEMBER 1, 2024

This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Sales and Company News Clinical trial optimization company PhaseV announced seven global pharma companies are using its machine learning platform for drug development.

eCare 90

eCare RCM Drug Development Accountable Care 90

Healthcare IT Today

DECEMBER 31, 2024

This collaboration will drive innovations such as faster drug development and coordinated patient care. Today, 20-35% of a study’s budget is spent on inefficient processes like data verification, driving a shift towards technologies that prioritize automation and integration.

Interoperability 63

Interoperability Health IT Pharmaceuticals Digital Health 63

Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.

Pharmaceuticals 167

Pharmaceuticals Drug Development Digital Health 167

Digital Health Global

FEBRUARY 19, 2024

This expansion mirrors a trend identified in an industry report jointly published by Biofourmis and HealthXL last year, predicting widespread adoption of digital endpoints by pharmaceutical companies in drug development programs by 2030.

Pharmaceuticals 166

Pharmaceuticals Drug Development Leadership Digital Health 166

ActiGraph

SEPTEMBER 23, 2021

Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.

Drug Development 52

Drug Development 52

ActiGraph

SEPTEMBER 23, 2021

Oncology is one of the most active and fastest growing areas of drug development research, outpacing other therapeutic areas in terms of study volume, complexity, cost, and duration.

Drug Development 52

Drug Development 52

Digital Health Global

APRIL 25, 2024

The study, led by principal investigator Nitin Ohri, M.D., The study, led by principal investigator Nitin Ohri, M.D., This pilot study represents a critical step in leveraging digital health technology to enhance cancer treatment outcomes,” said John Wagner, M.D., Chief Medical Officer, Koneksa. “By

Health Data 88

Health Data BioTech Drug Development healthcare technology 88

FierceHealthIT

MARCH 22, 2018

A new study finds that antibiotic resistance adds more than $1,000 to the cost of treatment for a single patient. The study’s authors urge policymakers to support the development of new strategies to prevent infections and to support innovative antibiotic drug development.

Drug Development 97

Drug Development 97

Digital Health Global

JANUARY 31, 2024

New study* reveals greater comprehension and personal engagement with enhanced e-consent PALO ALTO, Calif.–(BUSINESS The study population was diverse in gender, age, race, and geographic location. The enhanced eIC] is more appealing to me as a human being, not just a study subject,” said a 63-year-old male participant. “It

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Digital Health Global

MARCH 29, 2023

With ResponderID, we sought to disrupt the historical linear progression of drug discovery and development, rather aiming to close the loop between drug development, patient care and new drug discovery,” said Rafael Rosengarten, Ph.D., co-founder and CEO of Genialis. “We

Drug Development 128

Drug Development Pharmaceuticals Life Science Digital Health 128

Digital Health Global

JUNE 13, 2023

The LEARNS study will investigate the Koneksa neuroscience solution, as well as the Beacon Biosignals platform, applied to at-home EEG, compared with in-clinic polysomnography, in neurological and sleep disorders. The study will also evaluate whether assessment combinations can identify diagnostic features at the cohort diagnostic boundary.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Healthcare IT Today

NOVEMBER 6, 2023

PicnicHealth and AllStripes pioneered a new model by working directly with patients, which enables a deeper view of each patient’s health and experience while reducing the challenges of traditional site-based studies. Originally announced October 23rd, 2023

Life Science 117

Life Science Drug Development Patient Experience healthcare technology 117

Society for Participatory Medicine

FEBRUARY 1, 2023

The FDA issued a series of four patient-focused drug development (PFDD) guidance documents which outline how patient co-design needs to successfully happen. By the power vested in clinical research, the FDA now pronounces us patient and industry. You may now kiss the cancer survivor.

BioTech 112

BioTech Drug Development Meaningful Use Pharmaceuticals 112

Digital Health Global

NOVEMBER 30, 2023

Furthermore, by fostering connectivity and automating tasks, DHTs reduce administrative burdens, accelerate recruitment, and improve overall trial transparency, ultimately contributing to faster and more reliable drug development. It has been used in various studies in Europe with great results.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

ActiGraph

DECEMBER 27, 2021

Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites. The COVID-19 pandemic has completely changed the way we think about clinical research and care.

Drug Development 52

Drug Development 52

ActiGraph

SEPTEMBER 7, 2021

Clinical trials, a vital component of the drug development process, were heavily disrupted because patients, often with weakened immune systems, could not visit hospitals and research sites. The COVID-19 pandemic has completely changed the way we think about clinical research and care.

Drug Development 52

Drug Development 52

Digital Health Global

MARCH 2, 2023

As part of the partnership, SSI will expand Koneksa’s medical strategy division, especially in translational and clinical drug development. Koneksa clients gain access to a team of PhDs and MDs at SSI with expertise in drug development.

Drug Development 88

Drug Development Life Science BioTech Leadership 88

Digital Health Global

NOVEMBER 20, 2023

We believe Evinova’s combination of scientific expertise and track record in developing AI-enabled digital technologies at scale, provides a real opportunity to fundamentally improve patient care, drive healthcare transformation and reduce carbon emissions.” Deloitte pharma study: Drop-off in returns on R&D investments.

Life Science 88

Life Science Drug Development Digital Health Patient Experience 88

Digital Health Global

APRIL 25, 2025

The study externally evaluated Serial CTRS in GSKs GARNET Phase I clinical trial (NCT02715284) Cohort E, which enrolled patients with advanced non-small cell lung cancer (NSCLC) treated with dostarlimab, GSKs anti-PD-1 checkpoint inhibitor. Serial CTRS (CT Response Score) improves prediction of overall survival compared to RECIST 1.1

Drug Development 88

Drug Development Digital Health Pharmaceuticals 88

Healthcare IT Today

NOVEMBER 7, 2023

A recent Deloitte study estimates the average cost of developing a single new drug at $2.3 Moreover, the vast majority of drug candidates do not reach the finish line, and many fail the clinical phase even though the biology works. billion in 2022, with an average 7.1-year year deployment time.

Drug Development 70

Drug Development BioTech Pharmaceuticals Health IT 70

Digital Health Global

JANUARY 8, 2024

AI-powered* platform takes eCOA off the critical path to study startup for life sciences industry PALO ALTO, Calif.–(BUSINESS Early application of the technology in electronic clinical outcomes assessment (eCOA) deployments – a major delay to study startup industry-wide – is groundbreaking.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. DDR inhibitors are currently being tested in preclinical and clinical studies. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development 88

Drug Development Digital Health 88

Insulin Nation

OCTOBER 16, 2015

The announcement of the deal comes after Locemia has enjoyed a series of positive trial results for nasal glucagon in 2015; the most recent study data released showed the treatment proved safe for children , ages 4 to 17, with Type 1. The acquisition is an attempt by Lilly to bolster its troubled drug pipeline.

Pharmaceuticals 100

Pharmaceuticals Drug Development 100

Digital Health Global

JANUARY 4, 2024

This digital measurement model has already shown promise in early feasibility studies, and we look forward to applying this model into interventional trials with future partners and studies. Remote data collection also expands study accessibility, enabling a broader and more diverse representation of patients in clinical trials.

Health Technology 88

Health Technology Digital Health Drug Development healthcare technology 88

Digital Health Global

APRIL 5, 2024

Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Insulin Nation

NOVEMBER 27, 2018

Research & studies. In his studies, Type 1 diabetic patients have significantly benefited when their daily insulin regimen is supplemented with drugs developed to treat Type 2 diabetes. JDRF-funded triple therapy study. The goals for this JDRF-funded study include a 1.2% A1C reduction for each patient.

Drug Development 71

Drug Development 71

Society for Participatory Medicine

AUGUST 17, 2022

For a person like me, who is impacted by a rare, neurological, and incurable disease, it’s my mission to ensure that patients’ perspectives are represented early and throughout drug development. We plan to gather these stakeholders at the upcoming Huntington Study Group conference this November 3-5 in Tampa, FL, to develop next steps.

Drug Development 81

Drug Development BioTech 81

Digital Health Global

MARCH 26, 2024

Through this collaboration, Indivi will take over the digital management of Konectom TM in the Phase 2b LUMA study evaluating the efficacy and safety of BIIB122 in participants with early-stage Parkinson’s disease, which is being developed in collaboration with Denali Therapeutics Inc.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Digital Health Global

MAY 29, 2024

Partnership enables deeper evidence generation in clinical trials; early success in eight big-pharma-sponsored oncology studies PALO ALTO, Calif.–(BUSINESS –(BUSINESS WIRE)– Medable Inc. , Medable, which ranked in the top 8% of software companies on the 2023 Inc. in Phase III trials, respectively.

Drug Development 88

Drug Development Digital Health 88

DrKumo Remote Patient Monitoring

APRIL 12, 2022

Despite the numerous scientific studies demonstrating the efficacy and safety of metformin over the years, there are still some myths and misconceptions about its safety that hinder patient acceptance and adherence. 4,5,6 These studies, on the other hand, show that metformin does not raise the risk of heart safety problems.

Drug Development 97

Drug Development 97

Lloyd Price

MAY 16, 2023

Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Palantir's products are helping these organizations to improve patient care, accelerate research, and improve drug development. What are a few likely scenarios for Palantir in Healthcare? Have a comment?

Drug Development 92

Drug Development Health science Pharmaceuticals Public Health 92